Literature DB >> 15302743

Percutaneous tracheostomy is safe in patients with severe thrombocytopenia.

Stefan Kluge1, Andreas Meyer, Peter Kühnelt, Hans Jörg Baumann, Georg Kreymann.   

Abstract

STUDY
OBJECTIVES: Severe thrombocytopenia has been described as a contraindication for percutaneous tracheostomy (PT). The objective of this study was to assess the safety of PT in mechanically ventilated patients with severe thrombocytopenia (defined by a platelet count of < 50 x 10(9) cells/L).
DESIGN: Retrospective, single-center cohort study.
SETTING: Medical ICU of the University Hospital Hamburg-Eppendorf, Germany. PATIENTS: Forty-two medical patients with acute respiratory failure and severe thrombocytopenia.
INTERVENTIONS: Bedside PT under bronchoscopic guidance using the Griggs guidewire forceps technique.
MEASUREMENTS AND MAIN RESULTS: The mean (+/- SD) intubation time prior to undergoing PT was 6.7 +/- 3.9 days (range, 1 to 20 days). The mean platelet count was 26.4 +/- 11.6 x 10(9) cells/L (range, 1 x 10(9) to 47 x 10(9) cells/L). The median transfusion of platelets before the procedure in 40 of the 42 patients was 6 +/- 2.5 U (range, 3 to 12 U). Twenty-two patients (52%) had an additional coagulopathy (activated partial thromboplastin time [APTT], > 40 s; international normalized ratio, > 1.5). PT was safely performed in all 42 patients. Only two (5%) patients developed major postprocedural bleeding complications that required suturing. Both of these patients had an elevated APTT due to heparin therapy.
CONCLUSIONS: When performed by experienced personnel, PT with bronchoscopic guidance has a low complication rate in patients with severe thrombocytopenia, provided that platelets are administered beforehand. However, in order to minimize bleeding complications heparin infusions should be temporarily interrupted during the procedure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15302743     DOI: 10.1378/chest.126.2.547

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  20 in total

1.  Correction of subclinical coagulation disorders before percutaneous dilatational tracheotomy.

Authors:  Denise P Veelo; Alexander P Vlaar; Dave A Dongelmans; Jan M Binnekade; Marcel Levi; Frederique Paulus; Fenny Berends; Marcus J Schultz
Journal:  Blood Transfus       Date:  2012-02-13       Impact factor: 3.443

Review 2.  [Update on tracheotomy].

Authors:  S Braune; S Kluge
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-09-27       Impact factor: 0.840

Review 3.  Percutaneous tracheostomy: a comprehensive review.

Authors:  Ashraf O Rashid; Shaheen Islam
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

4.  Safety of percutaneous dilatational tracheostomy in patients on extracorporeal lung support.

Authors:  Stephan Braune; Susanne Kienast; Johannes Hadem; Olaf Wiesner; Dominic Wichmann; Axel Nierhaus; Marcel Simon; Tobias Welte; Stefan Kluge
Journal:  Intensive Care Med       Date:  2013-07-27       Impact factor: 17.440

5.  Transfusion of fresh frozen plasma in non-bleeding ICU patients--TOPIC trial: study protocol for a randomized controlled trial.

Authors:  Marcella C A Müller; Evert de Jonge; M Sesmu Arbous; Angelique M E Spoelstra-de Man; Atilla Karakus; Margreeth B Vroom; Nicole P Juffermans
Journal:  Trials       Date:  2011-12-23       Impact factor: 2.279

Review 6.  Clinical review: percutaneous dilatational tracheostomy.

Authors:  Mariam A Al-Ansari; Mohammed H Hijazi
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

7.  Percutaneous tracheostomy in patients on anticoagulants.

Authors:  Laura Pasin; Elena Frati; Luca Cabrini; Giovanni Landoni; Pasquale Nardelli; Tiziana Bove; Maria Grazia Calabro; Anna Mara Scandroglio; Federico Pappalardo; Alberto Zangrillo
Journal:  Ann Card Anaesth       Date:  2015 Jul-Sep

8.  Percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy: a prospective trial.

Authors:  Georg Auzinger; Gerry P O'Callaghan; William Bernal; Elizabeth Sizer; Julia A Wendon
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

9.  Tracheostomy must be individualized!

Authors:  Paolo Pelosi; Paolo Severgnini
Journal:  Crit Care       Date:  2004-09-08       Impact factor: 9.097

Review 10.  Death after percutaneous dilatational tracheostomy: a systematic review and analysis of risk factors.

Authors:  Marcel Simon; Maria Metschke; Stephan A Braune; Klaus Püschel; Stefan Kluge
Journal:  Crit Care       Date:  2013-10-29       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.